UNSPSC 51283715: Cefamandole sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C18H17N6O5S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IY6234ODVR, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-mandelamido-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, d- but more generally known as cefamandole sodium, which bears US NIH Compound Identifier 34779.

UNSPSC 51283715 Cefamandole sodium is a Commodity code that nominally describes a specific cephalosporin antibiotic, but recent state and local procurement activity under this code shows little or no alignment with that narrow scope. The two most recent opportunities tagged to this code — an Illinois Department of Public Health pharmaceutical warehouse piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems — do not involve cefamandole sodium at all. State and local purchasers appear to use this code inconsistently or to have mislabeled opportunities in their tagging systems. Pharmaceutical procurement through state and local channels does occur via piggyback agreements, cooperative purchasing consortia (such as MMCAP Infuse in the Illinois example), and direct IFB processes, but the specific commodity classification here does not reflect the actual drugs being sought.

The limited recent activity under this code occurs in Florida and Illinois. Without additional opportunities clearly tagged to cefamandole sodium or demonstrating consistent use of this Commodity code for its intended product, the code presents limited actionable opportunity for vendors specializing in this particular pharmaceutical. A vendor pursuing state and local pharmaceutical supply contracts should monitor broader pharmaceutical family codes and verify commodity-level tagging accuracy before responding to individual solicitations.